跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOLARAZE diclofenac sodium 3 % gel tube - TGA Drug Approval Details
Approvals
/
TGA
/
SOLARAZE diclofenac sodium 3 % gel tube
Approved
STANDARD
SOLARAZE diclofenac sodium 3 % gel tube
Mayne Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
a0003962d0fed525
Company
Mayne Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
a0003962d0fed525
Product Name
SOLARAZE diclofenac sodium 3 % gel tube
Artg Id
116785
Artg Name
SOLARAZE diclofenac sodium 3 % gel tube
Sponsor
Mayne Pharma International Pty Ltd
Company Detail Path
/organization/mayne-pharma-international-pty-ltd
Artg Date
2007-05-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/94fbd3ba30acc18355519c2d2866bab3.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4d4d8434f7f6e47b5041a3395c80737b.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
a0003962d0fed525
Type
Standard
Back to TGA Approvals